.: More pain ahead for mkts, gold up, rupee drops and other stories

Thursday, 13 February 2014

To ensure delivery directly to your inbox, Please add etnotifications@indiatimes.com to your address book today. If you are having trouble viewing this newsletter, please click here.

	Dated:13 February,2014

Top Headlines

Market has had a volatile start in terms of performance in 2014 as international news flow dominated the direction for the better part of the month.

Muted global cues & weak IIP numbers could be very much responsible for the kind of sell-off seen in Indian markets.

"I would say switch on from Cipla to Sun Pharma, in Cipla I do not think there is going to be much of positivities in the next couple of quarters."

Views on Stocks/Markets

IPO/Global Markets

Rupee / Gold

More 'Market' News

Cipla plunges over 8%, brokers slash target prices
Top brokerage firms slashed targets for Cipla after the drug major posted a consolidated net of Rs 284.31 cr for the quarter ended Dec 31, 2013.

Retail investor story falters: How to bring them to the trading ring
In the last two decades, too many scams, not only in the capital markets but in general, have left the investor very nervous.

Sensex down 255 points, drops most in 10 days; CIL, Cipla tank
The BSE index, which had gained 114 points in last two sessions, plunged 255.14 points, or 1.25 per cent, to end at 20,193.35.

Market Round-up

.